Division of Neonatology, The Children's Hospital of Philadelphia, Philadelphia, PA.
Department of Medical Ethics and Health Policy, The Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA.
Neoreviews. 2024 Mar 1;25(3):e127-e138. doi: 10.1542/neo.25-3-e127.
Clinicians practicing in a modern NICU are noticing an increase in the proportion of patients who undergo genetic testing as well as changes in the types of genetic testing patients receive. These trends are not surprising given the increasing recognition of the genetic causes of neonatal illness and recent advances in genetic technology. Yet, the expansion of genetic testing in the NICU also raises a number of ethical questions. In this article, we will review the ethical issues raised by genetic testing, with a focus on the practical implications for neonatologists. First, we outline the complexities of measuring benefit, or utility, for neonatal genetic testing. Next, we discuss potential harms such as inequity, unexpected findings, disability biases, and legal risks. Finally, we conclude with a discussion of ethical issues related to consent for genetic testing. Throughout this article, we highlight solutions to challenges toward the ultimate goal of minimizing harms and maximizing the substantial potential benefits of genetic medicine in the NICU.
在现代新生儿重症监护病房(NICU)工作的临床医生注意到,接受基因检测的患者比例以及患者接受的基因检测类型都在增加。鉴于新生儿疾病的遗传原因日益得到认可,以及遗传技术的最新进展,这些趋势并不奇怪。然而,NICU 中基因检测的扩展也引发了许多伦理问题。在本文中,我们将回顾基因检测引发的伦理问题,重点关注对新生儿科医生的实际影响。首先,我们概述了衡量新生儿基因检测效益或效用的复杂性。接下来,我们讨论了潜在的危害,如不公平、意外发现、残疾偏见和法律风险。最后,我们讨论了与基因检测同意相关的伦理问题。在整篇文章中,我们强调了解决挑战的方法,以实现将遗传医学在 NICU 中的潜在益处最大化并将其危害最小化的最终目标。